Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Mersebach · SciRah

Researcher profile · Semantic Scholar

H. Mersebach

Share profile

H. Mersebach — researcher profile on SciRah

h-index: 18
Works: 41
Citations: 1,806

Most-cited papers

Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials
R. Ratner, S. Gough, Chantal Mathieu, S. Del Prato +4 more
2012Diabetes, obesity and metabolism350 citations Open access
Semantic Scholar
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease
P. Rossing, F. Baeres, G. Bakris, H. Bosch-Traberg +10 more
2023Nephrology, Dialysis and Transplantation194 citations Open access
Semantic Scholar
Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects.
M. Hod, P. Damm, R. Kaaja, G. Visser +4 more
2008American Journal of Obstetrics and Gynecology179 citations
Semantic Scholar
Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naïve Patients With Type 2 Diabetes
S. Gough, A. Bhargava, R. Jain, H. Mersebach +2 more
2013Diabetes Care152 citations Open access
Semantic Scholar
Comparison of Insulin Degludec/Insulin Aspart and Biphasic Insulin Aspart 30 in Uncontrolled, Insulin-Treated Type 2 Diabetes: A Phase 3a, Randomized, Treat-to-Target Trial
G. Fulcher, J. Christiansen, G. Bantwal, M. Polaszewska-Muszyńska +3 more
2014Diabetes Care109 citations
Semantic Scholar
A New-Generation Ultra-Long-Acting Basal Insulin With a Bolus Boost Compared With Insulin Glargine in Insulin-Naïve People With Type 2 Diabetes
T. Heise, C. Tack, R. Cuddihy, J. Davidson +6 more
2011Diabetes Care103 citations Open access
Semantic Scholar
Insulin Degludec/Insulin Aspart Administered Once Daily at Any Meal, With Insulin Aspart at Other Meals Versus a Standard Basal-Bolus Regimen in Patients With Type 1 Diabetes
I. Hirsch, B. Bode, J. Courréges, Patrik Dykiel +5 more
2012Diabetes Care80 citations Open access
Semantic Scholar
Comparison of 2 intensification regimens with rapid-acting insulin aspart in type 2 diabetes mellitus inadequately controlled by once-daily insulin detemir and oral antidiabetes drugs: the step-wise randomized study.
L. Meneghini, H. Mersebach, Sudhesh Kumar, Anne Louise Svendsen +1 more
2011Endocrine Practice72 citations
Semantic Scholar
Poor pregnancy outcome in women with type 1 diabetes is predicted by elevated HbA1c and spikes of high glucose values in the third trimester
P. Damm, H. Mersebach, J. Råstam, R. Kaaja +3 more
2013Journal of Maternal-Fetal & Neonatal Medicine68 citations Open access
Semantic Scholar
Hypoglycemia in Type 1 Diabetic Pregnancy
S. Heller, P. Damm, H. Mersebach, T. Skjøth +5 more
2009Diabetes Care64 citations Open access
Semantic Scholar
Evaluation of insulin antibodies and placental transfer of insulin aspart in pregnant women with type 1 diabetes mellitus
D. R. McCance, P. Damm, E. Mathiesen, Moshe Hod +4 more
2008Diabetologia52 citations Open access
Semantic Scholar
Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density
H. Mersebach, Jan O. Johansson, Å. Rasmussen, B. Bengtsson +5 more
2007Genetics in Medicine52 citations Open access
Semantic Scholar
Elderly Patients with Diabetes Experience a Lower Rate of Nocturnal Hypoglycaemia with Insulin Degludec than with Insulin Glargine: A Meta-Analysis of Phase IIIa Trials
C. Sorli, M. Warren, D. Oyer, H. Mersebach +2 more
2013Drugs & Aging51 citations Open access
Semantic Scholar
Intestinal adsorption of levothyroxine by antacids and laxatives: case stories and in vitro experiments.
H. Mersebach, Å. Rasmussen, Lisbeth Kirkegaard, Ulla Feldt-Rasmussen
1999Acta Pharmacologica et Toxicologica48 citations Open access
Semantic Scholar
Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naïve Patients with Type 2 Diabetes: A Randomized Controlled Trial
Ajay Kumar, E. Franek, J. Wise, M. Niemeyer +2 more
2016PLoS ONE35 citations Open access
Semantic Scholar
Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal–bolus treatment in people with Type 1 diabetes: 1–year results from a randomized clinical trial (BOOST ® T1)
I. Hirsch, Edward Franek, H. Mersebach, L. Bardtrum +1 more
2016Diabetic Medicine32 citations Open access
Semantic Scholar
A Novel Insulin Combination of Insulin Degludec and Insulin Aspart Achieves a More Stable Overnight Glucose Profile Than Insulin Glargine: Results from Continuous Glucose Monitoring in a Proof-of-Concept Trial
A. Liebl, J. Davidson, H. Mersebach, Patrik Dykiel +2 more
2013Journal of Diabetes Science and Technology29 citations Open access
Semantic Scholar
Fabry Disease – A Metabolic Disorder with a Challenge for Endocrinologists?
U. Feldt-Rasmussen, Å. Rasmussen, H. Mersebach, K. Rosenberg +2 more
2002Hormone Research in Paediatrics25 citations
Semantic Scholar
PATIENTS ACHIEVING GOOD GLYCEMIC CONTROL (HBA1c <7%) EXPERIENCE A LOWER RATE OF HYPOGLYCEMIA WITH INSULIN DEGLUDEC THAN WITH INSULIN GLARGINE: A META-ANALYSIS OF PHASE 3A TRIALS.
D. Einhorn, Y. Handelsman, B. Bode, L. Endahl +2 more
2015Endocrine Practice17 citations
Semantic Scholar
Antibody response to insulin in children and adolescents with newly diagnosed Type 1 diabetes
H. Holmberg, H. Mersebach, K. Kanc, J. Ludvigsson
2008Diabetic Medicine17 citations
Semantic Scholar
Immune function during GH treatment in GH‐deficient adults: an 18‐month randomized, placebo‐controlled, double‐blinded trial
S. B. Sneppen, H. Mersebach, H. Ullum, U. Feldt-Rasmussen
2002Clinical Endocrinology15 citations
Semantic Scholar
200 U/ml Insulin Degludec Improves Glycemic Control Similar to Insulin Glargine with a Low Risk of Hypoglycemia in Insulin-naïve People with Type 2 Diabetes
R. Bergenstal, A. Bhargava, R. Jain, S. Ross +3 more
201214 citations
Semantic Scholar
Effect of Growth Hormone Replacement Therapy on Pituitary Hormone Secretion and Hormone Replacement Therapies in GHD Adults
E. Hubina, H. Mersebach, Å. Rasmussen, A. Juul +3 more
2004Hormone Research in Paediatrics12 citations
Semantic Scholar
Combined dietary and pharmacological weight management in obese hypopituitary patients.
H. Mersebach, M. Klose, O. Svendsen, A. Astrup +1 more
2004Obesity Research8 citations Open access
Semantic Scholar
Abnormal sympathoadrenal activity, but normal energy expenditure in hypopituitarism.
H. Mersebach, O. Svendsen, A. Astrup, U. Feldt-Rasmussen
2003Journal of Clinical Endocrinology and Metabolism5 citations
Semantic Scholar
Prospectively Planned Meta-Analysis comparing Hypoglycemia Rates of Insulin Degludec with those of Insulin Glargine
R. Ratner, S. Gough, C. Mathieu, S. Del Prato +4 more
20124 citations
Semantic Scholar
The STEPwise (TM) randomised, controlled, 48-week trial: intensifying treatment with stepwise addition of prandial insulin aspart, based on largest prandial glucose increment or largest meal, to once daily basal insulin detemir in subjects with type 2 diabetes
K. Hermansen, Sudhesh Kumar, H. Mersebach, Anne Louise Svendsen +1 more
20104 citations
Semantic Scholar
Growth hormone and body composition.
H. Mersebach, U. Feldt-Rasmussen
2005Frontiers of Hormone Research3 citations
Semantic Scholar
[Localized lipohypertrophy during growth hormone therapy].
H. Mersebach, U. Feldt-Rasmussen
2002Ugeskrift for læger3 citations
Semantic Scholar
FC 123: Baseline Characteristics of the Flow Trial Population: Kidney Outcomes Trial With Once-Weekly Semaglutide in People With Type 2 Diabetes and Chronic Kidney Disease
V. Perkovic, F. Baeres, G. Bakris, H. Bosch-Traberg +7 more
2022Nephrology, Dialysis and Transplantation2 citations
Semantic Scholar
Subjects Achieving Good Glycemic Control (HbA1c<7.0%) Experience a Lower Rate of Confirmed and Nocturnal-Confirmed Hypoglycemia with Insulin Degludec than with Insulin Glargine: A Meta-Analysis of Phase 3a Trials
D. Einhorn, Y. Handelsman, B. Bode, Lars Endahl +3 more
20132 citations
Semantic Scholar
Ultra-Long-Acting Basal Insulin With a Bolus Boost Compared With Insulin Glargine in Insulin-Naïve People With Type 2
T. Heise, C. Tack, R. Cuddihy, J. Davidson +6 more
20112 citations
Semantic Scholar
Subject Index Vol. 58, 2002
G. Valerio, A. D. Del Puente, A. E. Puente, P. Buono +32 more
2002Hormone Research in Paediatrics2 citations Open access
Semantic Scholar
Fabry disease: a new challenge in endocrinology and metabolism?
U. Feldt-Rasmussen, A. K. Rasmussen, H. Mersebach, K. Rosenberg +2 more
2002European Journal of Endocrinology2 citations
Semantic Scholar
Baseline cardiovascular risk in subjects with type 2 diabetes and chronic kidney disease from the FLOW trial
K. Mahaffey, F. Baeres, G. Bakris, H. Bosch-Traberg +8 more
2022European Heart Journal1 citations Open access
Semantic Scholar
747-P: Baseline Characteristics of Subjects in the Once-Weekly (OW) Semaglutide FLOW Kidney Outcomes Trial
R. Pratley, F. Baeres, G. Bakris, J. Lawson +6 more
2022Diabetes1 citations
Semantic Scholar
Lower Risk of Hypoglycemia with Insulin Degludec vs. Insulin Glargine in Patients Diagnosed with Type 2 Diabetes for >10 years: Meta-Analysis of 5 Randomized Trials
J. Vora, H. Rodbard, H. Mersebach, R. Kapur +1 more
20130 citations Open access
Semantic Scholar
Elderly Patients Experience a Lower Rate of Nocturnal Hypoglycemia with Insulin Degludec Than with Insulin Glargine: A Meta-Analysis of Phase 3a Trials
C. Sorli, M. Warren, H. Mersebach, T. Johansen +2 more
20130 citations Open access
Semantic Scholar
Case Study: Immunogenicity of Insulin
H. Mersebach, Fannie E. Smith, T. Sparre, L. Jensen
20080 citations
Semantic Scholar
Relationship between genotype and phenotype in 26 Danish patients with Fabry disease
H. Mersebach, C. Schiøtz, A. Rasmussen, K. Rosenberg +6 more
20020 citations
Semantic Scholar
[Fabry disease--a special therapy now available].
Å. K. Rasmussen, H. Mersebach, L. Hasholt, K. Rosenberg +2 more
2001Ugeskrift for læger0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Hasholt×6
Invite
L. Hasholt — researcher profile on SciRah
U. Feldt-Rasmussen×6
Invite
U. Feldt-Rasmussen — researcher profile on SciRah
B. Bode×5
Invite
B. Bode — researcher profile on SciRah
Å. Rasmussen×5
Invite
Å. Rasmussen — researcher profile on SciRah

×5

Invite

K. Rosenberg — researcher profile on SciRah

Invite

P. Rossing — researcher profile on SciRah

Invite

F. Baeres — researcher profile on SciRah

Invite

V. Perkovic — researcher profile on SciRah

Invite

K. Tuttle — researcher profile on SciRah

Invite

R. Pratley — researcher profile on SciRah

Invite

P. Damm — researcher profile on SciRah

Invite

S. Gough — researcher profile on SciRah